Published in Cell Stress Chaperones on November 01, 2011
HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med (2000) 6.20
Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle (2006) 3.21
Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol (2008) 2.78
Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol (2010) 2.48
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol (2007) 2.21
Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc (1995) 1.99
Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem (2006) 1.78
Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones (2010) 1.69
Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr (2007) 1.66
Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest (2007) 1.56
The dual immunoregulatory roles of stress proteins. Trends Biochem Sci (2008) 1.51
Heat shock proteins (chaperones) in fish and shellfish and their potential role in relation to fish health: a review. J Fish Dis (2010) 1.46
Epidemiology and genetics of alopecia areata. Clin Exp Dermatol (2002) 1.45
Alopecia areata. Int J Dermatol (2007) 1.45
Alopecia areata update: part II. Treatment. J Am Acad Dermatol (2010) 1.44
Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev (2005) 1.36
Onions: a source of unique dietary flavonoids. J Agric Food Chem (2007) 1.25
The hair follicle and immune privilege. J Investig Dermatol Symp Proc (2003) 1.10
Prevention of chemotherapy-induced alopecia in rodent models. Cell Stress Chaperones (2008) 1.06
Alopecia areata: clinical aspects. J Invest Dermatol (1991) 1.03
Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies. Cell Stress Chaperones (2009) 1.02
Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies. Cell Stress Chaperones (2010) 1.02
An update on alopecia areata. Curr Opin Pediatr (2009) 1.00
Cytokines and other mediators in alopecia areata. Mediators Inflamm (2010) 0.99
Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutr Res Pract (2011) 0.98
Alopecia areata: evidence-based treatments. Semin Cutan Med Surg (2009) 0.94
Immunosuppressive effect of quercetin on dendritic cell activation and function. J Immunol (2010) 0.94
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. J Med Chem (2009) 0.92
Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway. Immunobiology (2010) 0.92
Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. J Invest Dermatol (2002) 0.91
Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects. Cell Stress Chaperones (2008) 0.90
Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model. Cell Stress Chaperones (2010) 0.89
308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol (2009) 0.86
The pathogenesis of alopecia areata in rodent models. J Investig Dermatol Symp Proc (2003) 0.86
Complementary and alternative medicine in alopecia areata. Am J Clin Dermatol (2010) 0.85
Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. Eur J Nutr (2010) 0.84
Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules. Br J Nutr (2011) 0.84
308-nm excimer laser for the treatment of alopecia areata. Dermatol Surg (2007) 0.82
Onion juice (Allium cepa L.), a new topical treatment for alopecia areata. J Dermatol (2002) 0.82
Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol (2009) 0.82
Roles of heat shock proteins and gamma delta T cells in inflammation. Am J Respir Cell Mol Biol (2008) 0.81
Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol (2007) 0.80
The alchemy of immune privilege explored from a neuroimmunological perspective. Curr Opin Pharmacol (2008) 0.80
Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: a double-blind randomized controlled study. Indian J Dermatol Venereol Leprol (2007) 0.79
A non-targeted approach to chemical discrimination between green tea dietary supplements and green tea leaves by HPLC/MS. J AOAC Int (2011) 0.78
Effects of 6 weeks of quercetin supplementation on energy, fatigue, and sleep in ROTC cadets. Mil Med (2011) 0.78
Treatment of alopecia areata with 308-nm excimer lamp. J Dermatol (2010) 0.78
Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol (2010) 0.77
Kinetic characterization of a basic peroxidase from garlic (Allium sativum L.) cloves. J Food Sci (2011) 0.77
Effects of severe hypertension on endothelial and platelet microparticles. Hypertension (2003) 2.53
Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res (2003) 2.15
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol (2005) 1.96
Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol (2004) 1.81
High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J (2003) 1.79
Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol (2003) 1.72
Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation (2004) 1.65
Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation. Heart Rhythm (2005) 1.59
Endothelial microparticles as markers of endothelial dysfunction. Front Biosci (2004) 1.59
Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol (2006) 1.31
Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol (2011) 1.29
Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med (2005) 1.27
New horizons in the analysis of circulating cell-derived microparticles. Keio J Med (2004) 1.16
Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol (2004) 1.14
Prevention of chemotherapy-induced alopecia in rodent models. Cell Stress Chaperones (2008) 1.06
Induction of specific microRNAs inhibits cutaneous wound healing. J Biol Chem (2012) 1.04
Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci (2004) 1.03
Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res (2004) 1.01
Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol (2013) 0.98
Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb Res (2007) 0.97
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol (2014) 0.97
Cell-derived microparticles and exosomes in neuroinflammatory disorders. Int Rev Neurobiol (2007) 0.93
Vascular dementia in patients with immune thrombocytopenic purpura. Thromb Res (2002) 0.90
Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata. Lasers Med Sci (2011) 0.89
Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model. Cell Stress Chaperones (2010) 0.89
Images in clinical medicine. X-chromosomal translocation and segmental hypopigmentation. N Engl J Med (2012) 0.89
Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA). Lasers Med Sci (2012) 0.89
Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab. Acta Haematol (2003) 0.88
Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment. Pediatr Dermatol (2007) 0.87
Speckled lentiginous nevus syndrome: central nervous system abnormalities as a critical diagnostic feature. Pediatr Dermatol (2011) 0.87
Giant aplasia cutis congenita without associated anomalies. Pediatr Dermatol (2004) 0.85
Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men. Am J Cardiol (2005) 0.85
Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome. Br J Haematol (2003) 0.85
Management of epidermolysis bullosa in infants and children. Clin Dermatol (2003) 0.85
Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol (2007) 0.84
Endothelial microparticles (EMP) as vascular disease markers. Adv Clin Chem (2005) 0.83
Successful acne management in Apert syndrome twins. Pediatr Dermatol (2005) 0.81
Eruptive vellus hair cysts: a systematic review. Am J Clin Dermatol (2012) 0.80
Life-threatening hypercoagulable state following splenectomy in ITP: successful management with aggressive antithrombotic therapy and danazol. Clin Appl Thromb Hemost (2005) 0.79
Blau syndrome: a new kindred. J Am Acad Dermatol (2003) 0.79
Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission. Br J Haematol (2005) 0.79
Managing pediatric patients with psoriasis. Am J Clin Dermatol (2010) 0.79
What syndrome is this? Beare-Stevenson cutis gyrata syndrome. Pediatr Dermatol (2003) 0.78
Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis. J Am Acad Dermatol (2005) 0.78
S100-negative indeterminate cell histiocytosis in an African American child responsive to narrowband ultraviolet B. Pediatr Dermatol (2011) 0.78
Cutis tricolor. Cutis (2013) 0.78
HATS syndrome: hemimaxillary enlargement, asymmetry of the face, tooth abnormalities, and skin findings. Cutis (2014) 0.77
Cross-section Trichometry: A Clinical Tool for Assessing the Progression and Treatment Response of Alopecia. Int J Trichology (2012) 0.77
Cell-derived microparticles: a mediator of inflammation in aortic valve stenosis? Thromb Haemost (2008) 0.77
Infantile midline facial hemangioma with agenesis of the corpus callosum and sinus pericranii: another face of the PHACE syndrome. J Am Acad Dermatol (2006) 0.77
Linear morphea and leg length discrepancy: treatment with a leg-lengthening procedure. Pediatr Dermatol (2013) 0.75
Letter to the editor: Application of dapsone 5% gel in a patient with dermatitis herpetiformis. J Dermatol Case Rep (2012) 0.75
Is speckled lentiginous nevus really prone to dysplasia/neoplasia? Pediatr Dermatol (2012) 0.75
Speckled lentiginous nevus: sometimes, but not always, part of a syndrome. Neurol Sci (2011) 0.75
Picture of the month. Comèl-Netherton syndrome without bamboo hair. Arch Pediatr Adolesc Med (2011) 0.75
A rare presentation of squamous cell carcinoma in a patient with PIBIDS-type trichothiodystrophy. Pediatr Dermatol (2008) 0.75
Unilateral striae distensae affecting the right axilla in a 16-year-old boy: brief report. Pediatr Dermatol (2012) 0.75
A Consensus About the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants. J Drugs Dermatol (2020) 0.75
Transendothelial migration of leukocytes is promoted by plasma from a subgroup of immune thrombocytopenic purpura patients with small-vessel ischemic brain disease. Am J Hematol (2008) 0.75
Skin manifestations of Bardet-Biedl syndrome. Int J Dermatol (2011) 0.75
Fever and rash in a child: when to worry? Pediatr Ann (2007) 0.75
Disseminated superficial actinic porokeratosis associated with pseudoxanthoma elasticum. Eur J Dermatol (2011) 0.75
Trends and antibiotic susceptibility patterns of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in an outpatient dermatology facility. JAMA Dermatol (2013) 0.75
Facial angiofibromas in a mosaic pattern tuberous sclerosis: A case report. Dermatol Online J (2012) 0.75
Bilateral treatment for alopecia areata. Pediatr Dermatol (2010) 0.75
"Alternately divided" epidermal nevus of the fingers. Pediatr Dermatol (2011) 0.75
Segmental acne versus mosaic conditions with acne lesions. Dermatology (2012) 0.75
Congenital idiopathic atrophoderma of Pasini and Pierini. Dermatol Online J (2012) 0.75
Agonist-induced capping of adhesion proteins and microparticle shedding in cultures of human renal microvascular endothelial cells. Endothelium (2002) 0.75
Isolated systematized nevus flammeus. Int J Dermatol (2013) 0.75
Severe respiratory syncytial virus infection complicating treatment for infantile hemangioma. J Am Acad Dermatol (2010) 0.75